Clinical Trial Update: Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT [Phase 2]

View source ↗

Summary

Phase 2 bridging study evaluating elimination of minimal residual disease before hematopoietic cell transplantation in acute leukemia; study status terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2019-02-12